These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17372586)

  • 1. Adverse reactions and medical approach to paroxysmal nocturnal hemoglobinuria.
    Colombo GM; Guglielmelli E; Sacco T; Cicchinelli M
    Minerva Med; 2007 Feb; 98(1):87-8. PubMed ID: 17372586
    [No Abstract]   [Full Text] [Related]  

  • 2. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Takita M; Matsumura T; Kami M
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17193722
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
    Hill A
    Clin Adv Hematol Oncol; 2008 Jul; 6(7):499-500. PubMed ID: 18654116
    [No Abstract]   [Full Text] [Related]  

  • 4. Eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
    Hill A
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):849-50. PubMed ID: 16491626
    [No Abstract]   [Full Text] [Related]  

  • 5. Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):79-80. PubMed ID: 17878890
    [No Abstract]   [Full Text] [Related]  

  • 6. Update in paroxysmal nocturnal hemoglobinuria.
    Hillmen P
    Clin Adv Hematol Oncol; 2012 Jun; 10(6):391-3. PubMed ID: 22895241
    [No Abstract]   [Full Text] [Related]  

  • 7. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Pride YB
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17195305
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evidence of the efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria].
    Nau JY
    Rev Med Suisse; 2006 Oct; 2(81):2255. PubMed ID: 17076159
    [No Abstract]   [Full Text] [Related]  

  • 9. Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab.
    Danilov AV; Smith H; Craigo S; Feeney DM; Relias V; Miller KB
    Leuk Res; 2009 Jun; 33(6):e4-5. PubMed ID: 18952283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eculizumab in paroxysmal nocturnal hemoglobinuria].
    Birgens H
    Ugeskr Laeger; 2011 Mar; 173(10):714. PubMed ID: 21375975
    [No Abstract]   [Full Text] [Related]  

  • 11. Paroxysmal nocturnal hemoglobinuria and eculizumab.
    Luzzatto L; Risitano AM; Notaro R
    Haematologica; 2010 Apr; 95(4):523-6. PubMed ID: 20378572
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria.
    Berzuini A; Montanelli F; Prati D
    N Engl J Med; 2010 Sep; 363(10):993-4. PubMed ID: 20818912
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab.
    van Bijnen ST; Vermeer H; Mourisse JM; de Witte T; van Swieten HA; Muus P
    Eur J Haematol; 2011 Oct; 87(4):376-8. PubMed ID: 21623921
    [No Abstract]   [Full Text] [Related]  

  • 14. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Singh J; Malani AK; Pabla M
    N Engl J Med; 2006 Dec; 355(26):2786; author reply 2787-8. PubMed ID: 17195307
    [No Abstract]   [Full Text] [Related]  

  • 15. Eculizumab for patients with paroxysmal nocturnal hemoglobinuria (PNH) is effective during the maintenance of hemodialysis for end stage renal failure.
    Kelly RJ; Hill A; Arnold LM; Khursigara G; Kanagasundaram NS; Hillmen P
    Leuk Res; 2011 Apr; 35(4):560-2. PubMed ID: 21145109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria: a role of NKG2D-medicated immunity].
    Kawaguchi T
    Rinsho Ketsueki; 2010 Aug; 51(8):664-71. PubMed ID: 20805673
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathophysiology and treatment of paroxysmal nocturnal hemoglobinuria (PNH)--recent advances].
    Shichishima A; Shichishima T;
    Rinsho Ketsueki; 2009 Dec; 50(12):1679-86. PubMed ID: 20068274
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving renal outcomes in chronic anemia: learning from paroxysmal nocturnal hemoglobinuria.
    Guasch A
    Am J Hematol; 2010 Aug; 85(8):551-2. PubMed ID: 20658585
    [No Abstract]   [Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria turning Coombs-positive.
    Röth A; Peine S; Dührsen U
    Int J Hematol; 2010 Mar; 91(2):159-60. PubMed ID: 20140782
    [No Abstract]   [Full Text] [Related]  

  • 20. Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria.
    Knoll BM; Letendre L; Steensma DP
    Am J Hematol; 2008 Nov; 83(11):881-3. PubMed ID: 18756538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.